Lakewood-Amedex reports positive Nu-3 MIC data in diabetic foot ulcer isolates
The company said the lab data were presented and support continued development of Nu-3, now in a Phase 2a topical trial.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Lakewood-Amedex Biotherapeutics reports positive data from diabetic foot ulcer isolates
Lakewood-Amedex Biotherapeutics said it had positive data against recent clinical isolates from infected diabetic foot ulcers.